---
title: "Genedx Holdings Insider Bought Shares Worth $46,806,729, According to a Recent SEC Filing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286062621.md"
description: "Keith A. Meister, a 10% owner and director of Genedx Holdings, purchased 1,205,147 shares for $46,806,729 on May 7, 2026. Following this transaction, he controls a total of 4,786,570 Class A common shares, with 20,129 shares held directly and 4,766,441 shares controlled indirectly, as reported in a recent SEC filing."
datetime: "2026-05-12T08:26:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286062621.md)
  - [en](https://longbridge.com/en/news/286062621.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286062621.md)
---

# Genedx Holdings Insider Bought Shares Worth $46,806,729, According to a Recent SEC Filing

04:26 AM EDT, 05/12/2026 (MT Newswires) -- Keith A. Meister, 10% Owner, Director, on May 07, 2026, executed a purchase for 1,205,147 shares in Genedx Holdings ( WGS ) for $46,806,729. Following the Form 4 filing with the SEC, Meister has control over a total of 4,786,570 Class A common shares of the company, with 20,129 shares held directly and 4,766,441 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1818331/000101143826000276/xslF345X05/form4.xml

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [WGS.US](https://longbridge.com/en/quote/WGS.US.md)
- [IDNA.US](https://longbridge.com/en/quote/IDNA.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [WGSWW.US](https://longbridge.com/en/quote/WGSWW.US.md)

## Related News & Research

- [Genprex data shows gene therapy reverses hyperglycemia in T2D mice at ASGCT](https://longbridge.com/en/news/286414681.md)
- [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)
- [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)
- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)